IRIS
SASSO, Ferdinando Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.118
NA - Nord America 8.456
AS - Asia 7.172
SA - Sud America 1.077
Continente sconosciuto - Info sul continente non disponibili 518
AF - Africa 98
OC - Oceania 10
Totale 33.449
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 10.978
US - Stati Uniti d'America 8.253
SG - Singapore 2.376
CN - Cina 1.554
IE - Irlanda 1.353
IT - Italia 1.324
VN - Vietnam 1.052
HK - Hong Kong 1.044
BR - Brasile 894
DE - Germania 530
GB - Regno Unito 525
UA - Ucraina 410
KR - Corea 304
IN - India 289
SE - Svezia 217
FR - Francia 209
FI - Finlandia 151
JP - Giappone 146
CA - Canada 104
TR - Turchia 101
GR - Grecia 99
BD - Bangladesh 82
NL - Olanda 82
AR - Argentina 70
MX - Messico 53
AT - Austria 38
ID - Indonesia 38
CZ - Repubblica Ceca 36
PL - Polonia 31
EC - Ecuador 29
ZA - Sudafrica 29
ES - Italia 28
IQ - Iraq 27
BE - Belgio 24
CO - Colombia 22
PK - Pakistan 18
VE - Venezuela 18
MA - Marocco 16
EG - Egitto 14
LT - Lituania 14
CH - Svizzera 13
IR - Iran 13
UZ - Uzbekistan 12
DK - Danimarca 11
IL - Israele 11
PY - Paraguay 11
SA - Arabia Saudita 11
CR - Costa Rica 10
PE - Perù 10
PT - Portogallo 10
UY - Uruguay 10
AU - Australia 9
CL - Cile 9
MY - Malesia 9
SC - Seychelles 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
JO - Giordania 8
RO - Romania 7
AZ - Azerbaigian 6
NP - Nepal 6
OM - Oman 6
TT - Trinidad e Tobago 6
EU - Europa 5
GE - Georgia 5
TW - Taiwan 5
BB - Barbados 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
SI - Slovenia 4
TH - Thailandia 4
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
EE - Estonia 3
KW - Kuwait 3
NG - Nigeria 3
PH - Filippine 3
RS - Serbia 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AN - Antille olandesi 1
Totale 32.913
Salva come PNG Salva come JPEG
Città #
Moscow 3.991
Dublin 1.324
San Jose 1.246
Singapore 1.085
Hong Kong 1.009
Santa Clara 829
Chandler 692
Jacksonville 623
Ashburn 490
Dallas 343
Ho Chi Minh City 340
The Dalles 306
Seoul 292
Hefei 291
Council Bluffs 280
Naples 280
Hanoi 247
Beijing 210
New York 205
Bengaluru 192
Princeton 176
Medford 133
Munich 131
Los Angeles 130
Roxbury 121
Ann Arbor 108
Bremen 101
Boardman 90
Wilmington 83
São Paulo 82
Caserta 72
Woodbridge 72
Da Nang 67
San Mateo 65
Nanjing 63
Haiphong 57
Cambridge 54
Orem 53
Milan 46
Memphis 44
Amsterdam 43
Des Moines 43
Aversa 38
Frankfurt am Main 38
Rome 37
Chicago 35
Houston 34
Falkenstein 31
Tokyo 31
Düsseldorf 29
Montreal 29
Napoli 29
Rio de Janeiro 29
Salerno 29
Helsinki 27
Jinan 26
Mountain View 26
Tianjin 26
Atlanta 25
Brooklyn 25
Brussels 24
Ercolano 24
Mexico City 24
Phoenix 24
Chennai 23
Hải Dương 22
Nuremberg 22
Shanghai 22
Kunming 21
Kochi 20
Biên Hòa 19
Bắc Ninh 19
Istanbul 19
Seattle 19
Turku 19
Changsha 18
London 18
Shenyang 18
Belo Horizonte 17
Boston 17
Brno 17
Toronto 17
Vienna 17
Brasília 16
Denver 16
Ottawa 16
Stockholm 16
Nanchang 15
Norwalk 15
Paris 15
Warsaw 15
Florence 14
Giugliano In Campania 14
Hillsboro 14
San Francisco 14
Lappeenranta 13
Porto Alegre 13
Thái Bình 13
Zhengzhou 13
Bari 12
Totale 17.357
Salva come PNG Salva come JPEG
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 343
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 277
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 232
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 225
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. 208
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 206
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 203
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 201
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 189
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 189
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 187
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 186
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 186
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 186
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 185
Aminotrasferase activity and acarbose treatment in patients with type 2 diabetes 184
MiRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes 184
[Surgical treatment and interventional therapy in cerebral ischemia] 182
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 172
esults from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. 171
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 169
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 168
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 167
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 167
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 166
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 164
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 164
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 162
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 162
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 161
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 160
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 159
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 159
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 158
Predictors of early and late hepatocellular carcinoma recurrence 158
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 157
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 157
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 156
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 156
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 155
EFFECT OFTREATMENT WITH ACARBOSE,AN A-GLUCOSIDASE INHIBITOR ANDINSULIN IN PATIENT WITH NON-INSULIN-DEPENDENTDIABETESMELLITUS NON ALCOLIC LIVER CIRRHOSIS 155
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 155
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 155
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 155
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 154
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 154
Aminotransferase activity and acarbose treatment in patients with type 2 diabetes 154
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 153
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 152
[Inhibitors of the platelet's receptor GPIIb/IIIA. Progress in the treatment of acute myocardial ischemia and future trends] 150
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 149
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 148
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 148
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 148
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment 147
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 144
Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha 144
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 144
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 143
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 143
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 143
Disfunzione renale nell’anziano: processo fisiologico o malattia? 143
Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome 142
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 142
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 141
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. 141
Effects of stress hyperglicemia on acute myocardial infarction 141
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 140
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 140
A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy 139
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 139
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 137
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. 137
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 137
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 136
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 136
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 136
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels 136
HCC and molecular targeting therapies: Back to the future 136
Cardiovascular benefits from gliflozins: Effects on endothelial function 136
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 135
Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study 135
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 135
Multi-detector row CT for depicting anatomic features of cephalothoracopagus varieties: revised approach 135
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction. 135
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 135
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 135
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 135
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 134
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 134
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 134
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 134
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment 134
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 134
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 134
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 133
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 132
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 131
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 131
A case of anaplastic thyroid carcinoma with exceptional growth. 131
Totale 15.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.221 0 0 28 60 421 29 32 36 70 108 108 329
2022/20232.682 222 75 62 213 291 225 12 164 1.255 44 58 61
2023/20241.450 117 77 74 129 377 170 21 50 19 71 123 222
2024/20254.354 45 85 37 115 640 477 627 377 689 478 398 386
2025/202619.503 826 1.064 1.111 816 1.590 10.205 1.237 796 716 498 374 270
2026/20271.174 178 472 524 0 0 0 0 0 0 0 0 0
Totale 33.449